U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Lorazepam Injection
Status: Currently in Shortage
»Date first posted: 05/03/2018
»Therapeutic Categories: Neurology

Expand all

Amphastar Pharmaceuticals, Inc. (Reverified 07/19/2024)

Company Contact Information:
800-423-4136

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 2 mg/1 mL (NDC 76329-8261-1) Limited Availability Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (Reverified 07/01/2024)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ativan Injection (lorazepam injection, USP), Injection, 2 mg/1 mL (NDC 0641-6001-25) Unavailable Product will be made available as it is released. Demand increase for the drug
Ativan Injection (lorazepam injection, USP), Injection, 2 mg/1 mL (NDC 0641-6000-10) Unavailable Additional lots are scheduled to be manufactured. Product will be made available as it is released. Demand increase for the drug
Ativan Injection (lorazepam injection, USP), Injection, 4 mg/1 mL (NDC 0641-6003-25) Unavailable Additional lots are scheduled to be manufactured. Product will be made available as it is released. Demand increase for the drug
Ativan Injection (lorazepam injection, USP), Injection, 4 mg/1 mL (NDC 0641-6002-10) Unavailable Additional lots are scheduled to be manufactured. Product will be made available as it is released. Demand increase for the drug
Lorazepam injection, USP, Injection, 2 mg/1 mL (NDC 0641-6044-25) Unavailable Product will be made available as it is released. Demand increase for the drug
Lorazepam injection, USP, Injection, 2 mg/1 mL (NDC 0641-6046-10) Unavailable Additional lots are scheduled to be manufactured. Product will be made available as it is released. Demand increase for the drug
Lorazepam injection, USP, Injection, 4 mg/1 mL (NDC 0641-6045-25) Unavailable Additional lots are scheduled to be manufactured. Product will be made available as it is released. Demand increase for the drug
Lorazepam injection, USP, Injection, 4 mg/1 mL (NDC 0641-6002-10) Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.

Hospira, Inc., a Pfizer Company (Revised 07/15/2024)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30) Limited Availability Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: September 2024 Demand increase for the drug
Back to Top